Nicholas Investment Partners, LP Vista Gen Therapeutics, Inc. Transaction History

Nicholas Investment Partners, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$0.88 - $1.73 $100,804 - $198,173	-114,551 Reduced 2.51%	4,455,836 $3.92 Million
Q1 2022 May 10, 2022	BUY	$1.14 - $2.09 $321,833 - $590,027	282,310 Added 6.58%	4,570,387 $5.67 Million
Q4 2021 Feb 14, 2022	BUY	$1.67 - $2.76 $2.51 Million - $4.14 Million	1,501,723 Added 53.9%	4,288,077 $8.36 Million
Q3 2021 Nov 15, 2021	BUY	$2.62 - $3.45 $85,081 - $112,035	32,474 Added 1.18%	2,786,354 $7.64 Million
Q2 2021 Aug 10, 2021	BUY	$1.96 - $3.15 $1.16 Million - $1.87 Million	592,878 Added 27.44%	2,753,880 $8.68 Million

Q1 2021 May 14, 2021	BUY	$1.89 - $2.96 $4.08 Million - $6.4 Million	2,161,002 New	2,161,002 $4.6 Million

2.7M

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $730M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Nicholas Investment Partners, LP with notifications on news.